Low glycemic snacks

At ONE Bite, we understand the growing concerns of aging, obesity, and pre-diabetes

Understanding the links between aging, obesity, and pre-diabetes is vital. The aging population is growing globally, obesity rates are soaring (42.4% in the U.S. in 2017-2018), and pre-diabetes affects approximately 470 million people worldwide, greatly increasing the risk of type 2 diabetes. Aging often leads to increased fat mass, exacerbating obesity, which is itself a major risk factor for pre-diabetes. Maintaining a low glycemic index can help prevent and even reverse these health issues.

Sources: СВС; The Lancet; The Journal of the American Geriatrics Society; ADA.

How We Formulate?

Partnered with a Medical Advisory Board
Comprising healthcare professionals and organizations with expertise in nutrition and diabetes management, this team of experts provides invaluable guidance in the development of our snack formulas.
We create snacks that are backed by science
Through extensive knowledge and experience, we create snacks that are backed by science and aligned with the latest research on gastroenterology and gerontology.

What Have We Done?

With the guidance of our Medical Advisory Board, we have formulated a unique line of low glycemic snacks tailored to the needs of individuals managing their blood glucose levels and who care about longevity, health, and beauty.

Science-based complex

Click to explore innovative components.
lowers incremental glucose and insulin response by half, significantly lowers the postprandial response.
reduces the risk of blood clots forming in overweight, obese or sedentary populations
BENEO oligofructose
lowers and balances blood sugar rise.
improves insulin sensitivity and glucose metabolism
Rosemary extract
exhibits protective properties against hyperlipidemia and hyperglycemia.

ONE Bite is the first science-backed low GI snack brand that is clinically proven and formulated by a team of medical experts and nutritionists.

According to the studies, selected components could affect the cellular level, improve insulin resistance, break down Advanced Glycation End products (AGE), and influence epigenetic modulation.

Sources: 2023 Tate&Lyle; www.beneo.com; Thompson et al Br J Nutr (2017) 118:368–374; Kuwahara M, Kim HK, Nutrients, 2020;12:1580; Saeid Golbidi, Front Pharmacol. 2011; 2: 69.